News & Updates
Filter by Specialty:
Intravesical pembrolizumab delivers antitumour activity in NMIBC
08 Sep 2022
byTristan Manalac
A recent first-in-human study has shown that directly applying pembrolizumab to the bladder is a safe and effective treatment option for patients with nonmuscle-invasive bladder cancer (NMIBC) who are unresponsive to bacillus Calmette-Guérin (BCG) treatment.
Intravesical pembrolizumab delivers antitumour activity in NMIBC
08 Sep 2022
Shift work carries higher cardiometabolic multimorbidity risk in hypertension
08 Sep 2022
Hypertensive patients who work shifts face an increased risk of developing more than two cardiometabolic diseases or cardiometabolic multimorbidity, according to a study.
Shift work carries higher cardiometabolic multimorbidity risk in hypertension
08 Sep 2022
Atrial fibrillation in DM tied to end-stage renal disease
08 Sep 2022
Patients with diabetes mellitus (DM) who also have atrial fibrillation (AF) are at a heightened risk of developing end-stage renal disease (ESRD), a recent study has found.